Ajesh Shrivastava: Difference between revisions
m (Wikiflux moved page Ajesh Shrivastava to Draft:Ajesh Shrivastava) |
No edit summary |
||
| Line 51: | Line 51: | ||
=='''Social Links'''== | =='''Social Links'''== | ||
* [https://www.facebook.com/share/1ANow4C1iP/ Facebook – Ajesh Shrivastava] | * [https://www.facebook.com/share/1ANow4C1iP/ Facebook – Ajesh Shrivastava] | ||
* [https://www.instagram.com/ | * [https://www.instagram.com/ajeshsrivastava Instagram – Ajesh Shrivastava] | ||
Revision as of 10:03, 16 December 2025
Ajesh Shrivastava is an Indian pharmaceutical professional and entrepreneur recognized for his leadership in the healthcare and pharmaceutical industry. He is the Managing Director of OXXYL PHARMA PVT LTD, a company established in January 2025 with a focus on ethical and sustainable pharmaceutical solutions. With more than ten years of experience in the pharma sector, Shrivastava has built a reputation for results-driven management and operational expertise. His professional journey reflects a steady progression from field-level sales roles to corporate leadership. He is based in Delhi and continues to contribute to the evolving pharmaceutical landscape in India.
Early Life and Background
Ajesh Shrivastava was born on 15 June 1989 in Agra, Uttar Pradesh, India. He was raised in a supportive family environment by his father, Anil Kumar Shrivastava, and his mother, Shashi Shrivastava. Growing up in Agra, he developed an early interest in science and healthcare, which later influenced his academic and professional choices.
He pursued higher education in the field of life sciences and earned a Bachelor of Science degree in Biotechnology from Dr. B. R. Ambedkar University, Agra. His academic background provided him with foundational knowledge of biological sciences and pharmaceutical principles, preparing him for a career in the healthcare industry.
Career
Shrivastava began his professional career in the pharmaceutical industry as a sales executive. Over the next decade, he gained extensive hands-on experience across various aspects of pharma sales, marketing, and field operations. His work involved building relationships with healthcare professionals, understanding market dynamics, and promoting pharmaceutical products in competitive environments.
With approximately ten years of experience in the pharma sector, he developed a strong understanding of industry standards, regulatory awareness, and business development strategies. His long-term exposure to the operational side of pharmaceuticals played a key role in shaping his entrepreneurial ambitions.
On 9 January 2025, Ajesh Shrivastava founded OXXYL PHARMA PVT LTD, marking a significant milestone in his career. As Managing Director, he oversees strategic planning, business development, and organizational growth. The company aims to deliver reliable healthcare products while maintaining ethical practices and quality-driven operations within the pharmaceutical market.
Achievements and Recognition
While Shrivastava has not been publicly associated with formal awards, his primary recognition lies in his sustained career growth and transition from a sales professional to a company founder. Establishing OXXYL PHARMA PVT LTD is considered a major professional achievement, reflecting his industry experience and entrepreneurial vision. His work emphasizes quality assurance, trust-building, and long-term sustainability in pharmaceutical business practices.
Personal Life
Ajesh Shrivastava is married to Saroj Shrivastava and resides in Delhi, India. Despite his professional commitments, he maintains close ties to his hometown of Agra. He is known to value discipline and consistency, traits that align closely with his professional philosophy. He follows Hinduism and holds Indian nationality.
Legacy and Future Plans
Shrivastava’s long-term vision centers on expanding OXXYL PHARMA PVT LTD into a trusted name within the Indian pharmaceutical sector. He aims to contribute to ethical healthcare delivery by focusing on quality products and responsible business practices. As his company grows, he is expected to play a broader role in shaping sustainable pharma entrepreneurship.